Lørenskog nursing home is one of five dedicated Development Center for nursing homes in the local government caretaker sector. The Akershus center will apply for membership in Oslo Medtech, to gain access to innovation and innovation expertise.
- The Development Center for nursing homes` strategy is to develop through knowledge, that’s the headline. The government reform in the health sector, Samhandlingsreformen, charts a course for us, but at the same time, when we think of innovation, we sweat! Innovation, R&D and the local government health sector are two different worlds. The local government is short on both money and time to test new technologies and solutions that can enable us to deliver better services within today’s budgets, says Arnfinn Gisleberg, CEO of Lørenskog nursing home.
- And not least, we are uncertain what to find and what to ask for.
That’s why he wants to enter Oslo Medtech. With the number of elderly needing care on a steep rise in the coming years, but still strong budget constraints, the caretaker sector need to innovate itself.
Traditionally the innovation in the health sector has taken place within the specialist health services, where R&D has a long history and tradition. But Gisleberg sees a strong potential to develop the same mechanisms in the local caretaking sector.
- But we need help from the medtech sector to identify our need, and to get to know the products and possibilities. The local government caretaker sector can be a significant market for the medtech industry, and an interesting arena for medtech entrepreneurs and product development, says Gisleberg.
Lørenskog nursing home has already established cooperation with Oslo Medtech member firm Otivio, to do clinical trials for Otivios medical devices. The project is funded by the Regional Research Fund – Hovedstaden.
- This is the first time a local nursing home receives this kind of grants. And we are, in fact, not bureaucratic. The time span from when we entered into the agreement with Otivio to the start of the clinical trials is short; we were able to respond quickly. And since we are a part of the Development Center for nursing homes in this region, we can provide Otivio with sufficient patients needed for the trials. I think this shows that we can be an interesting contributor to the medtech industry and facilitate for R&D and innovation, says Gisleberg.
- Also, the energy Oslo Medtech and CEO Kathrine Myhre radiate appeals to us and suits us very well here at Lørenskog, says Gisleberg.